Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 2212-2217

  Waguespack, Steven G ^a   Hui, Siu L ^a   White, Kenneth E ^a   Buckwalter, Kenneth A ^a   Econs, Michael J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CL 459 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CREATINE KINASE BB;

ADOLESCENT; ADULT; AGED; ALBERS SCHOENBERG DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD LEVEL; BONE RADIOGRAPHY; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FAMILY STUDY; FEMALE; HETEROZYGOTE DETECTION; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PENETRANCE; PRIORITY JOURNAL; SCREENING TEST;

EID: 0036090343     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.8497     Document Type: Article

References (45)

1. Röntgenbilder einer seltenen knochenerkrankung
2. Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form
3. Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): Clinical and radiological manifestations in 42 patients
4. Autosomal dominant osteopetrosis: Clinical severity and natural history
5. Osteopetrosis in adults
6. Osteopetrosis. A morphological study of twenty-one cases
7. Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: A study of two radiological types
8. Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis
9. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis
10. Serum creatine kinase isoenzyme BB in mammalian osteopetrosis
11. Elevated levels of creatine kinase BB isoenzyme in three patients with adult osteopetrosis
12. Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II-a family study
13. Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II
14. Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders
15. The rapid appearance of acid phosphatase activity at the developing ruffled border of parathyroid hormone activated medullary bone osteoclasts
16. Osteoclast molecular phenotyping by random cDNA sequencing
17. Creatine kinase activity is required for mineral deposition and matrix synthesis in endochondral growth cartilage
18. Developmental regulation of creatine kinase activity in cells of the epiphyseal growth cartilage
19. Tartrate-resistant acid phosphatase activity in tibial osteoclasts and cells elicited by ectopic bone and suture implants in normal and osteopetrotic rats
20. Cellular differences in acid phosphatase isoenzymes in bone and teeth
21. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function
22. Osteopetrosis. A genetic and epidemiological study
23. Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier
24. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: Potential use to assess bone resorption
25. Creatine kinase isoenzyme BB in serum of healthy adults and children
26. Creatine kinase isoenzymes in serum from children - Especially focusing on CK-BB
27. Age-related reference intervals for creatine kinase BB in serum
28. Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption
29. Clinical and biological aspects of acid phosphatase
30. Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children
31. Acid phosphatase in Gaucher's disease
32. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption
33. Creatine kinase isoenzymes: Electrophoretic and quantitative measurements
34. Creatine kinase in human tissues
35. Tissue- and cell-specific distribution of creatine kinase B: A new and highly specific monoclonal antibody for use in immunohistochemistry
36. Creatine kinase BB isoenzyme activity in bone-marrow serum
37. Creatine kinase isoenzyme BB increased in serum and tumor tissue of patients with giant cell tumor of bone
38. Brain creatine kinase in blood after acute brain injury
39. Creatine kinase isoenzyme BB activity in serum of a patient with gastric cancer
40. Clinical implications of creatine kinase-BB isoenzyme
41. Elevation of creatine kinase BB CK in hospitalized patients. Importance of distinguishing BB CK from MB CK
42. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase
43. Inhibition of osteoclastic acid phosphatase abolishes bone resorption
44. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis
45. Stimulation of a Gs-like G protein in the osteoclast inhibits bone resorption but enhances tartrate-resistant acid phosphatase secretion